-
1 Comment
PCAS SA is currently in a long term uptrend where the price is trading 11.1% above its 200 day moving average.
From a valuation standpoint, the stock is 96.6% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.9.
PCAS SA's total revenue sank by 0.0% to $49M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 25.4% to $11M since the same quarter in the previous year.
Based on the above factors, PCAS SA gets an overall score of 3/5.
Exchange | PA |
---|---|
CurrencyCode | EUR |
ISIN | FR0000053514 |
Sector | Basic Materials |
Industry | Chemicals |
Market Cap | 110M |
---|---|
PE Ratio | 12.5 |
Target Price | 14.5 |
Dividend Yield | 0.0% |
Beta | 0.37 |
PCAS SA develops and produces complex molecules for life sciences and specialty chemicals markets. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PCA.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025